{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:37:11Z","timestamp":1785285431529,"version":"3.55.0"},"reference-count":58,"publisher":"Medicinska Naklada d.o.o.","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychiat Danub"],"published-print":{"date-parts":[[2025,11,28]]},"DOI":"10.24869\/psyd.2025.295","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T10:15:43Z","timestamp":1764324943000},"page":"295-309","source":"Crossref","is-referenced-by-count":3,"title":["Dopamine dysfunction beyond psychosis: Reevaluating its role in depression, anxiety, and obsessive-compulsive disorder"],"prefix":"10.24869","volume":"37","author":[{"name":"Khalifa University, United Arab Emirates","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samy","family":"Mansour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahd","family":"Abdelrahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Khalifa University, United Arab Emirates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish","family":"Banwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Camali Clinic, United Arab Emirates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6768","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Ang, Y.-S., Cusin, C., Petibon, Y., Dillon, D. G., Breiger, M., Belleau, E. L., Normandin, M., Schroder, H., Boyden, S., & Hayden, E. (2022). A multi-pronged investigation of option generation using depression, PET and modafinil. Brain, 145(5), 1854-1865.https:\/\/doi.org\/10.1093\/brain\/awab429","DOI":"10.1093\/brain\/awab429"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Arjmand, S., Behzadi, M., Stephens, G. J., Ezzatabadipour, S., Seifaddini, R., Arjmand, S., & Shabani, M. (2018). A brain on a roller coaster: can the dopamine reward system act as a protagonist to subdue the ups and downs of bipolar disorder? The Neuroscientist, 24(5), 423-439.https:\/\/doi.org\/10.1177\/1073858417714226","DOI":"10.1177\/1073858417714226"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Ashok, A. H., Marques, T. R., Jauhar, S., Nour, M. M., Goodwin, G. M., Young, A. H., & Howes, O. D. (2017). The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment. Molecular Psychiatry, 22(5), 666-679.https:\/\/doi.org\/10.1038\/mp.2017.16","DOI":"10.1038\/mp.2017.16"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Azadmarzabadi, E., Haghighatfard, A., & Mohammadi, A. (2018). Low resilience to stress is associated with candidate gene expression alterations in the dopaminergic signalling pathway. Psychogeriatrics, 18(3), 190-201.https:\/\/doi.org\/10.1111\/psyg.12312","DOI":"10.1111\/psyg.12312"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Bekhbat, M., Li, Z., Mehta, N. D., Treadway, M. T., Lucido, M. J., Woolwine, B. J., Haroon, E., Miller, A. H., & Felger, J. C. (2022). Functional connectivity in reward circuitry and symptoms of anhedonia as therapeutic targets in depression with high inflammation: evidence from a dopamine challenge study. Molecular Psychiatry, 27(10), 4113-4121. https:\/\/doi.org\/10.1038\/s41380-022-01715-3","DOI":"10.1038\/s41380-022-01715-3"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Belkacemi, L., & Darmani, N. A. (2020). Dopamine receptors in emesis: Molecular mechanisms and potential therapeutic function. Pharmacological Research, 161, 105124.https:\/\/doi.org\/10.1016\/j.phrs.2020.105124","DOI":"10.1016\/j.phrs.2020.105124"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Berry, A. S., White, R. L., Furman, D. J., Naskolnakorn, J. R., Shah, V. D., D'Esposito, M., & Jagust, W. J. (2019). Dopaminergic mechanisms underlying normal variation in trait anxiety. Journal of Neuroscience, 39(14), 2735-2744. https:\/\/doi.org\/10.1523\/jneurosci.2382-18.2019","DOI":"10.1523\/JNEUROSCI.2382-18.2019"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Blagotin\u0161ek Cokan, K., Mavri, M., Rutland, C. S., Gli\u0161i\u0107, S., Sen\u0107anski, M., Vrecl, M., & Kubale, V. (2020). Critical impact of different conserved endoplasmic retention motifs and dopamine receptor interacting proteins (DRIPs) on intracellular localization and trafficking of the D2 dopamine receptor (D2-R) isoforms. Biomolecules, 10(10), 1355. https:\/\/doi.org\/10.3390\/biom10101355","DOI":"10.3390\/biom10101355"},{"key":"ref8","unstructured":"Brankovi\u0107, S. (2015). Boredom, dopamine, and the thrill of psychosis: psychiatry in a new key. Psychiatria Danubina, 27(2), 0-137."},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Braverman, E. R., Dennen, C. A., Gold, M. S., Bowirrat, A., Gupta, A., Baron, D., Roy, A. K., Smith, D. E., Cadet, J. L., & Blum, K. (2022). Proposing a \"brain health checkup (BHC)\" as a global potential \"standard of care\" to overcome reward dysregulation in primary care medicine: coupling genetic risk testing and induction of \"dopamine homeostasis\". International Journal of Environmental Research and Public Health, 19(9), 5480.https:\/\/doi.org\/10.3390\/ijerph19095480","DOI":"10.3390\/ijerph19095480"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Butini, S., Nikolic, K., Kassel, S., Br\u00fcckmann, H., Filipic, S., Agbaba, D., Gemma, S., Brogi, S., Brindisi, M., & Campiani, G. (2016). Polypharmacology of dopamine receptor ligands. Progress in Neurobiology, 142, 68-103.https:\/\/doi.org\/10.1016\/j.pneurobio.2016.03.011","DOI":"10.1016\/j.pneurobio.2016.03.011"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Chu, C. S., Chu, C. L., Liang, C. K., Lu, T., Lin, Y. T., Chou, M. Y., & Chow, P. C. K. (2019). Association Between Polymorphisms in Dopamine\u2010Related Genes and Orthopedic Pain Expression in a Chinese Elderly Population. Pain Practice, 19(2), 211-221.https:\/\/doi.org\/10.1111\/papr.12737","DOI":"10.1111\/papr.12737"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Costello, H., Yamamori, Y., Reeves, S., Schrag, A.-E., Howard, R., & Roiser, J. P. (2023). Longitudinal decline in striatal dopamine transporter binding in Parkinson's disease: associations with apathy and anhedonia. Journal of Neurology, Neurosurgery & Psychiatry, 94(10), 863-870.https:\/\/doi.org\/10.1136\/jnnp-2022-330790","DOI":"10.1136\/jnnp-2022-330790"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci13020349","article-title":"Combining Transcranial Magnetic Stimulation and Deep Brain Stimulation: Current Knowledge, Relevance and Future Perspectives","author":"D'Onofrio","year":"2023","unstructured":"D'Onofrio, V., Manzo, N., Guerra, A., Landi, A., Baro, V., M\u00e4\u00e4tt\u00e4, S., Weis, L., Porcaro, C., Corbetta, M., Antonini, A., & Ferreri, F. (2023). Combining Transcranial Magnetic Stimulation and Deep Brain Stimulation: Current Knowledge, Relevance and Future Perspectives. Brain Sci, 13(2).10.3390\/brainsci13020349","journal-title":"Brain Sci 13(2)"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Dretsch, M. N., Williams, K., Emmerich, T., Crynen, G., Ait\u2010Ghezala, G., Chaytow, H., Mathura, V., Crawford, F. C., & Iverson, G. L. (2016). Brain\u2010derived neurotropic factor polymorphisms, traumatic stress, mild traumatic brain injury, and combat exposure contribute to postdeployment traumatic stress. Brain and Behavior, 6(1), e00392.https:\/\/doi.org\/10.1002\/brb3.392","DOI":"10.1002\/brb3.392"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Felger, J. C. (2016). The role of dopamine in inflammation-associated depression: mechanisms and therapeutic implications. Inflammation-Associated Depression: Evidence, Mechanisms and Implications, 199-219.https:\/\/doi.org\/10.1007\/7854_2016_13","DOI":"10.1007\/7854_2016_13"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Fraporti, T. T., Contini, V., Tovo-Rodrigues, L., Recamonde-Mendoza, M., Rovaris, D. L., Rohde, L. A., Hutz, M. H., Salatino-Oliveira, A., & Genro, J. P. (2019). Synergistic effects between ADORA2A and DRD2 genes on anxiety disorders in children with ADHD. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 93, 214-220. https:\/\/doi.org\/10.1016\/j.pnpbp.2019.03.021","DOI":"10.1016\/j.pnpbp.2019.03.021"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Frosini, D., Unti, E., Guidoccio, F., Del Gamba, C., Puccini, G., Volterrani, D., Bonuccelli, U., & Ceravolo, R. (2015). Mesolimbic dopaminergic dysfunction in Parkinson's disease depression: evidence from a 123I-FP-CIT SPECT investigation. Journal of Neural Transmission, 122, 1143-1147. https:\/\/doi.org\/10.1007\/s00702-015-1370-z","DOI":"10.1007\/s00702-015-1370-z"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Gass\u00f3, P., Ortiz, A. E., Mas, S., Morer, A., Calvo, A., Bargall\u00f3, N., Lafuente, A., & L\u00e1zaro, L. (2015). Association between genetic variants related to glutamatergic, dopaminergic and neurodevelopment pathways and white matter microstructure in child and adolescent patients with obsessive-compulsive disorder. Journal of Affective Disorders, 186, 284-292.https:\/\/doi.org\/10.1016\/j.jad.2015.07.035","DOI":"10.1016\/j.jad.2015.07.035"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Gervasini, G., Gonz\u00e1lez, L. M., Gamero-Villarroel, C., Mota-Zamorano, S., Carrillo, J. A., Flores, I., & Garc\u00eda-Herr\u00e1iz, A. (2018). Effect of dopamine receptor D4 (DRD4) haplotypes on general psychopathology in patients with eating disorders. Gene, 654, 43-48.https:\/\/doi.org\/10.1016\/j.gene.2018.02.035","DOI":"10.1016\/j.gene.2018.02.035"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Goltz, F., van der Heide, A., & Helmich, R. C. (2024). Alleviating Stress in Parkinson's Disease: Symptomatic Treatment, Disease Modification, or Both? Journal of Parkinson's Disease, 14(s1), S147-S158.https:\/\/doi.org\/10.3233\/jpd-230211","DOI":"10.3233\/JPD-230211"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Gonz\u00e1lez-Arancibia, C., Urrutia-Pi\u00f1ones, J., Illanes-Gonz\u00e1lez, J., Martinez-Pinto, J., Sotomayor-Z\u00e1rate, R., Julio-Pieper, M., & Bravo, J. A. (2019). Do your gut microbes affect your brain dopamine? Psychopharmacology, 236, 1611-1622.https:\/\/doi.org\/10.1007\/s00213-019-05265-5","DOI":"10.1007\/s00213-019-05265-5"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Hamilton, J. P., Sacchet, M. D., Hj\u00f8rnevik, T., Chin, F. T., Shen, B., K\u00e4mpe, R., Park, J. H., Knutson, B. D., Williams, L. M., & Borg, N. (2018). Striatal dopamine deficits predict reductions in striatal functional connectivity in major depression: a concurrent 11C-raclopride positron emission tomography and functional magnetic resonance imaging investigation. Translational Psychiatry, 8(1), 264.https:\/\/doi.org\/10.1038\/s41398-018-0316-2","DOI":"10.1038\/s41398-018-0316-2"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Handley, E. D., Russotti, J., Ross, A. J., Toth, S. L., & Cicchetti, D. (2023). A person\u2010centered data analytic approach to dopaminergic polygenic moderation of child maltreatment exposure. Developmental Psychobiology, 65(5), e22403.https:\/\/doi.org\/10.1002\/dev.22403","DOI":"10.1002\/dev.22403"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Heyl, D. L., Champion, M., Muterspaugh, R., Connolly, M., Baraka, A., Khazaei, P., Moe, B., Al\u2010Sheemary, Z., Jaber, N., & Guy\u2010Evans, H. (2019). Characterizing the binding of dopamine D1-D2 receptors in vitro and in temporal and frontal lobe tissue total protein. FEBS letters, 593(7), 732-742. https:\/\/doi.org\/10.1002\/1873-3468.13351","DOI":"10.1002\/1873-3468.13351"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Hjorth, O. R., Frick, A., Gingnell, M., Hoppe, J. M., Faria, V., Hultberg, S., Alaie, I., M\u00e5nsson, K. N., Ros\u00e9n, J., & Reis, M. (2021). Expectancy effects on serotonin and dopamine transporters during SSRI treatment of social anxiety disorder: a randomized clinical trial. Translational Psychiatry, 11(1), 559.https:\/\/doi.org\/10.1038\/s41398-021-01682-3","DOI":"10.1038\/s41398-021-01682-3"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Hjorth, O. R., Frick, A., Gingnell, M., Hoppe, J. M., Faria, V., Hultberg, S., Alaie, I., M\u00e5nsson, K. N., Wahlstedt, K., & Jonasson, M. (2021). Expression and co-expression of serotonin and dopamine transporters in social anxiety disorder: a multitracer positron emission tomography study. Molecular Psychiatry, 26(8), 3970-3979.https:\/\/doi.org\/10.1038\/s41380-019-0618-7","DOI":"10.1038\/s41380-019-0618-7"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Iaccarino, L., Sala, A., Caminiti, S. P., Presotto, L., Perani, D., & Initiative, A. s. D. N. (2020). In vivo MRI structural and PET metabolic connectivity study of dopamine pathways in Alzheimer's disease. Journal of Alzheimer's Disease, 75(3), 1003-1016.https:\/\/doi.org\/10.3233\/jad-190954","DOI":"10.3233\/JAD-190954"},{"key":"ref28","unstructured":"Jab\u0142o\u0144ski, M., Jasiewicz, A., Kucharska-Mazur, J., Samochowiec, J., Bienkowski, P., Mierzejewski, P., & Samochowiec, A. (2013). The effect of selected polymorphisms of the dopamine receptor gene DRD2 and the ANKK-1 on the preference of concentrations of sucrose solutions in men with alcohol dependence. Psychiatria Danubina, 25(4), 0-378."},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Kaitz, M., Mankuta, D., Rokem, A. M., & Faraone, S. (2016). Dopamine receptor polymorphism modulates the relation between antenatal maternal anxiety and fetal movement. Developmental Psychobiology, 58(8), 980-989.https:\/\/doi.org\/10.1002\/dev.21428","DOI":"10.1002\/dev.21428"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Kanarik, M., Grimm, O., Mota, N. R., Reif, A., & Harro, J. (2022). ADHD co-morbidities: A review of implication of gene\u00d7 environment effects with dopamine-related genes. Neuroscience & Biobehavioral Reviews, 139, 104757.https:\/\/doi.org\/10.1016\/j.neubiorev.2022.104757","DOI":"10.1016\/j.neubiorev.2022.104757"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Kinney, K. R., & Hanlon, C. A. (2022). Changing cerebral blood flow, glucose metabolism, and dopamine binding through transcranial magnetic stimulation: a systematic review of transcranial magnetic stimulation-positron emission tomography literature. Pharmacological Reviews, 74(4), 918-932. https:\/\/doi.org\/10.1124\/pharmrev.122.000579","DOI":"10.1124\/pharmrev.122.000579"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Kwon, O.-B., Lee, J. H., Kim, H. J., Lee, S., Lee, S., Jeong, M.-J., Kim, S.-J., Jo, H.-J., Ko, B., & Chang, S. (2015). Dopamine regulation of amygdala inhibitory circuits for expression of learned fear. Neuron, 88(2), 378-389.https:\/\/doi.org\/10.1016\/j.neuron.2015.09.001","DOI":"10.1016\/j.neuron.2015.09.001"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Lee, L.-T., Tsai, H. C., Chi, M. H., Chang, W. H., Chen, K. C., Lee, I. H., Chen, P. S., Yao, W. J., Chiu, N. T., & Yang, Y. K. (2015). Lower availability of striatal dopamine transporter in generalized anxiety disorder: a preliminary two-ligand SPECT study. International Clinical Psychopharmacology, 30(3), 175-178. https:\/\/doi.org\/10.1097\/yic.0000000000000067","DOI":"10.1097\/YIC.0000000000000067"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Liu, Y., Admon, R., Mellem, M. S., Belleau, E. L., Kaiser, R. H., Clegg, R., Beltzer, M., Goer, F., Vitaliano, G., & Ahammad, P. (2020). Machine learning identifies large-scale reward-related activity modulated by dopaminergic enhancement in major depression. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 5(2), 163-172.https:\/\/doi.org\/10.1016\/j.bpsc.2019.10.002","DOI":"10.1016\/j.bpsc.2019.10.002"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Mal\u00e9n, T., Santavirta, S., De Maeyer, S., Tuisku, J., Kaasinen, V., Kankare, T., Isoj\u00e4rvi, J., Rinne, J., Hietala, J., & Nuutila, P. (2024). Alterations in type 2 dopamine receptors across neuropsychiatric conditions: A large-scale PET cohort. NeuroImage: Clinical, 41, 103578.https:\/\/doi.org\/10.1016\/j.nicl.2024.103578","DOI":"10.1016\/j.nicl.2024.103578"},{"issue":"3","key":"ref36","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.biopsych.2009.07.037","article-title":"Dopamine type 2\/3 receptor availability in the striatum and social status in human volunteers","volume":"67","author":"Martinez","year":"2010","unstructured":"Martinez, D., Orlowska, D., Narendran, R., Slifstein, M., Liu, F., Kumar, D., Broft, A., Van Heertum, R., & Kleber, H. D. (2010). Dopamine type 2\/3 receptor availability in the striatum and social status in human volunteers. Biological Psychiatry, 67(3), 275-278.","journal-title":"Biological Psychiatry"},{"issue":"4","key":"ref37","doi-asserted-by":"publisher","first-page":"917","DOI":"10.3171\/2015.4.JNS15120","article-title":"Neurosurgery for schizophrenia: an update on pathophysiology and a novel therapeutic target","volume":"124","author":"Mikell","year":"2016","unstructured":"Mikell, C. B., Sinha, S., & Sheth, S. A. (2016). Neurosurgery for schizophrenia: an update on pathophysiology and a novel therapeutic target. Journal of Neurosurgery, 124(4), 917-928. https:\/\/pubmed.ncbi.nlm.nih.gov\/26517767\/","journal-title":"Journal of Neurosurgery"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Mitchell, J. M., Weinstein, D., Vega, T., & Kayser, A. S. (2018). Dopamine, time perception, and future time perspective. Psychopharmacology, 235, 2783-2793.https:\/\/doi.org\/10.1007\/s00213-018-4971-z","DOI":"10.1007\/s00213-018-4971-z"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Mizuno, Y., Ashok, A. H., Bhat, B. B., Jauhar, S., & Howes, O. D. (2023). Dopamine in major depressive disorder: A systematic review and meta-analysis of in vivo imaging studies. Journal of Psychopharmacology, 37(11), 1058-1069.https:\/\/doi.org\/10.1177\/02698811231200881","DOI":"10.1177\/02698811231200881"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Murray, G. K., Knolle, F., Ersche, K. D., Craig, K. J., Abbott, S., Shabbir, S. S., Fineberg, N. A., Suckling, J., Sahakian, B. J., & Bullmore, E. T. (2019). Dopaminergic drug treatment remediates exaggerated cingulate prediction error responses in obsessive-compulsive disorder. Psychopharmacology, 236, 2325-2336.https:\/\/doi.org\/10.1007\/s00213-019-05292-2","DOI":"10.1007\/s00213-019-05292-2"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Nikolaus, S., Mamlins, E., Hautzel, H., & M\u00fcller, H.-W. (2019). Acute anxiety disorder, major depressive disorder, bipolar disorder and schizophrenia are related to different patterns of nigrostriatal and mesolimbic dopamine dysfunction. Reviews in the Neurosciences, 30(4), 381-426.https:\/\/doi.org\/10.1515\/revneuro-2018-0037","DOI":"10.1515\/revneuro-2018-0037"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Peci\u00f1a, M., Sikora, M., Avery, E. T., Heffernan, J., Peci\u00f1a, S., Mickey, B. J., & Zubieta, J.-K. (2017). Striatal dopamine D2\/3 receptor-mediated neurotransmission in major depression: Implications for anhedonia, anxiety and treatment response. European Neuropsychopharmacology, 27(10), 977-986.https:\/\/doi.org\/10.1016\/j.euroneuro.2017.08.427","DOI":"10.1016\/j.euroneuro.2017.08.427"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Picillo, M., Santangelo, G., Erro, R., Cozzolino, A., Amboni, M., Vitale, C., Barone, P., & Pellecchia, M. T. (2017). Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease. Parkinsonism & Related Disorders, 37, 106-110.https:\/\/doi.org\/10.1016\/j.parkreldis.2017.02.010","DOI":"10.1016\/j.parkreldis.2017.02.010"},{"key":"ref44","unstructured":"Pirto\u0161ek, Z. (2011). Myths and realities of continuous dopaminergic stimulation. Psychiatria Danubina, 23(1.), 80-83."},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Saloner, R., Cherner, M., Grelotti, D. J., Paolillo, E. W., Moore, D. J., Heaton, R. K., Letendre, S. L., Kumar, A., Grant, I., & Ellis, R. J. (2020). Lower CSF homovanillic acid relates to higher burden of neuroinflammation and depression in people with HIV disease. Brain, Behavior, and Immunity, 90, 353-363.https:\/\/doi.org\/10.1016\/j.bbi.2020.09.012","DOI":"10.1016\/j.bbi.2020.09.012"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"Santangelo, G., Vitale, C., Picillo, M., Cuoco, S., Moccia, M., Pezzella, D., Erro, R., Longo, K., Vicidomini, C., & Pellecchia, M. T. (2015). Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients. Parkinsonism & Related Disorders, 21(5), 489-493.https:\/\/doi.org\/10.1016\/j.parkreldis.2015.02.015","DOI":"10.1016\/j.parkreldis.2015.02.015"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Sekiguchi, H., Pavey, G., & Dean, B. (2023). Altered levels of dopamine transporter in the frontal pole and the striatum in mood disorders: A postmortem study. Journal of Affective Disorders, 320, 313-318.https:\/\/doi.org\/10.1016\/j.jad.2022.09.065","DOI":"10.1016\/j.jad.2022.09.065"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"Serafini, R. A., Pryce, K. D., & Zachariou, V. (2020). The mesolimbic dopamine system in chronic pain and associated affective comorbidities. Biological Psychiatry, 87(1), 64-73. https:\/\/doi.org\/10.1016\/j.biopsych.2019.10.018","DOI":"10.1016\/j.biopsych.2019.10.018"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"Terr\u00f3n-D\u00edaz, M. E., Wright, S. J., Agosto, M. A., Lichtarge, O., & Wensel, T. G. (2019). Residues and residue pairs of evolutionary importance differentially direct signaling bias of D2 dopamine receptors. Journal of Biological Chemistry, 294(50), 19279-19291.https:\/\/doi.org\/10.1074\/jbc.ra119.008068","DOI":"10.1074\/jbc.RA119.008068"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"Tiger, M., Svensson, J., Liberg, B., Saijo, T., Schain, M., Halldin, C., Farde, L., & Lundberg, J. (2020). [11C] raclopride positron emission tomography study of dopamine\u2010D2\/3 receptor binding in patients with severe major depressive episodes before and after electroconvulsive therapy and compared to control subjects. Psychiatry and Clinical Neurosciences, 74(4), 263-269.https:\/\/doi.org\/10.1111\/pcn.12980","DOI":"10.1111\/pcn.12980"},{"issue":"4","key":"ref51","doi-asserted-by":"publisher","first-page":"9256","DOI":"10.4088\/JCP.20m13229","article-title":"Symptom dimension of interest-activity indicates need for aripiprazole augmentation of escitalopram in major depressive disorder: a CAN-BIND-1 report","volume":"81","author":"Uher","year":"2020","unstructured":"Uher, R., Frey, B. N., Quilty, L. C., Rotzinger, S., Blier, P., Foster, J. A., M\u00fcller, D. J., Ravindran, A. V., Soares, C. N., & Turecki, G. (2020). Symptom dimension of interest-activity indicates need for aripiprazole augmentation of escitalopram in major depressive disorder: a CAN-BIND-1 report. The Journal of Clinical Psychiatry, 81(4), 9256.","journal-title":"The Journal of Clinical Psychiatry"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"Vassena, E., Van Opstal, F., Goethals, I., & Verguts, T. (2019). Striatal dopamine D2 binding correlates with locus of control: Preliminary evidence from [11C] raclopride Positron Emission Tomography. International Journal of Psychophysiology, 146, 117-124.https:\/\/doi.org\/10.1016\/j.ijpsycho.2019.09.016","DOI":"10.1016\/j.ijpsycho.2019.09.016"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"Wang, F., Xin, M., Li, X., Li, L., Wang, C., Dai, L., Zheng, C., Cao, K., Yang, X., & Ge, Q. (2024). Effects of deep brain stimulation on dopamine D2 receptor binding in patients with treatment-refractory depression. Journal of Affective Disorders, 356, 672-680.https:\/\/doi.org\/10.1016\/j.jad.2024.04.082","DOI":"10.1016\/j.jad.2024.04.082"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"Wang, H., Zhao, Y., & Schrag, A. (2023). Development of anxiety in early Parkinson's disease: a clinical and biomarker study. European Journal of Neurology, 30(9), 2661-2668.https:\/\/doi.org\/10.1111\/ene.15890","DOI":"10.1111\/ene.15890"},{"issue":"12","key":"ref55","doi-asserted-by":"publisher","first-page":"8341","DOI":"10.1039\/D2CP05676C","article-title":"A multiple-step screening protocol to identify norepinephrine and dopamine reuptake inhibitors for depression","volume":"25","author":"Wang","year":"2023","unstructured":"Wang, P., Yan, F., Dong, J., Wang, S., Shi, Y., Zhu, M., Zuo, Y., Ma, H., Xue, R., & Zhai, D. (2023). A multiple-step screening protocol to identify norepinephrine and dopamine reuptake inhibitors for depression. Physical Chemistry Chemical Physics, 25(12), 8341-8354.10.1039\/D2CP05676C","journal-title":"Physical Chemistry Chemical Physics"},{"key":"ref56","doi-asserted-by":"publisher","unstructured":"Whitton, A. E., Reinen, J. M., Slifstein, M., Ang, Y.-S., McGrath, P. J., Iosifescu, D. V., Abi-Dargham, A., Pizzagalli, D. A., & Schneier, F. R. (2020). Baseline reward processing and ventrostriatal dopamine function are associated with pramipexole response in depression. Brain, 143(2), 701-710.https:\/\/doi.org\/10.1093\/brain\/awaa002","DOI":"10.1093\/brain\/awaa002"},{"key":"ref57","doi-asserted-by":"publisher","unstructured":"Yang, Z., Xie, Y., Dou, K., Yang, L., & Xie, A. (2023). Associations of striatal dopamine transporter binding with motor and non\u2010motor symptoms in early Parkinson's disease. Clinical and Translational Science, 16(6), 1021-1038.https:\/\/doi.org\/10.1111\/cts.13508","DOI":"10.1111\/cts.13508"}],"container-title":["PSYCHIATRIA DANUBINA"],"original-title":["Dopamine dysfunction beyond psychosis: Reevaluating its role in depression, anxiety, and obsessive-compulsive disorder"],"link":[{"URL":"https:\/\/www.psychiatria-danubina.com\/UserDocsImages\/pdf\/dnb_vol37_no3\/dnb_vol37_no3_295.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T12:22:25Z","timestamp":1780316545000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.psychiatria-danubina.com\/UserDocsImages\/pdf\/dnb_vol37_no3\/dnb_vol37_no3_295.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":58,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,11,28]]},"published-print":{"date-parts":[[2025,11,28]]}},"URL":"https:\/\/doi.org\/10.24869\/psyd.2025.295","relation":{},"ISSN":["0353-5053"],"issn-type":[{"value":"0353-5053","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,28]]}}}